Salam salamat

Actoverco Pharmaceutical Company

tirzeptide

Tirzepatide vs. Semaglutide for Weight Loss: Which Is More Effective?

Tirzepatide and semaglutide are two newer medications that have gained significant attention in the field of weight management. Both medications can help with weight control

tirzacto

What Are the Side Effects of GIP/GLP-1?

Weight loss injections, including GLP-1 receptor agonists and related medications, are used to support blood glucose control and weight management in people with conditions such

tirzacto

How to Inject Weight Loss Injections?

Most injectable weight management medications, including GLP-1 receptor agonists and related therapies, are designed for convenient self-administration at home. These medications are injected subcutaneously, meaning

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

Actover Pharmaceutical Group, with active participation in the 10th edition of the Pharmaceutical and Related Industries Exhibition (IRAN PHARMA), hosted chief executives of several pharmaceutical

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

The first National Conference on “Health Product Vigilance” was held on the occasion of World Patient Safety Day by the Deputy for Food and Drug

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

Here’s the English translation of that sentence: **The oral capsule *Zeponim* (Ozanimod), developed by specialists at Alborz Zagros Pharmaceutical Company — a subsidiary of Actover

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements.

Actoverco Showcases Cardiovascular Portfolio at the 10th Joint Iranian Congress of Cardiology and Cardiovascular Surgery

The 10th Joint Iranian Congress of Cardiology and Cardiovascular Surgery was held from April 28 to May 1, 2025, at the Shaheed Rajaie Cardiovascular Medical

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

Tehran, May 2025 — Actover Pharmaceutical Group participated in the 32nd Iranian Congress of Neurology and Clinical Electrophysiology, presenting a wide range of its neurological

Labor Day Tribute from Actoverco

International Labor Day is a global tribute to the unwavering will and tireless hands that shape the future. It is a meaningful occasion to honor

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

Eid al-Fitr, a celebration of devotion and righteousness, marks the dawn of divine mercy and the season of harvesting the vibrant fruits of answered prayers.

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

The first session of the AcTrip (Actoverco Thyroid Insight Practice) conference series, organized by Actoverco Pharmaceutical Group, was held with the aim of reviewing the